FindTrial
Sign In

RANDOMIZED MULTICENTER STUDY ON DALTEPARIN TREATMENT IN IVF PATIENTS - ND

RANDOMIZED MULTICENTER STUDY ON DALTEPARIN TREATMENT IN IVF PATIENTS - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-005409-22-IT
Enrollment
Unknown
Registered
2008-04-09
Start date
2007-09-03
Completion date
Unknown
Last updated
2014-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

couple infertility MedDRA version: 9.1 Level: LLT Classification code 10021928 Term: Infertility female

Interventions

Trade Name: FRAGMIN Pharmaceutical Form: Solution for injection INN or Proposed INN: Dalteparin Concentration unit: U unit(s) Concentration type: equal Concentration number: 2500-

Sponsors

AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: first treatment cycle; no inherited trombophilia; patients age =65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: no first treatment cycle; inherited trombophilia; patients age > 40

Design outcomes

Primary

MeasureTime frame
Main Objective: DALTEPARIN TREATMENT INCREASES IMPLANTATION RATE;Secondary Objective: increase of clinical pregnancies in IFV patients;Primary end point(s): DALTEPARIN TREATMENT INCREASES IMPLANTATION RATE—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026